Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study. (2020). Reumatismo, 72(1), 52-59. https://doi.org/10.4081/reumatismo.2020.1266